Bacteremia in feverish children presenting to the emergency department: a retrospective study and literature review

Aim:  To evaluate the incidence of bacteremia, and the isolated pathogens, in well‐appearing children with fever without source (FWS) presenting to the pediatric emergency department (PED), after pneumococcal conjucate vaccine ‐ 7 valent (PCV‐7) widespread introduction in the Veneto region of north‐eastern Italy, and to review the main literature contributions on the subject.

[1]  E. Purssell Feverish illness in children Assessment and initial management in children younger than 5 years , 2013 .

[2]  J. Trainor,et al.  Fever without a localizing source. , 2011, Pediatric annals.

[3]  J. Benito-Fernández,et al.  PNEUMOCOCCAL BACTEREMIA IN FEBRILE INFANTS PRESENTING TO THE EMERGENCY DEPARTMENT 8 YEARS AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE IN THE BASQUE COUNTRY OF SPAIN , 2010, The Pediatric infectious disease journal.

[4]  E. Alpern,et al.  Occult Pneumococcal Bacteremia: A Review , 2010, Pediatric emergency care.

[5]  S. Mintegi,et al.  Blood Culture and Bacteremia Predictors in Infants Less Than Three Months of Age With Fever Without Source , 2010, The Pediatric infectious disease journal.

[6]  S. Mintegi,et al.  Predictors of occult bacteremia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine , 2009, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[7]  R. Riffenburgh,et al.  Serious bacterial infections in febrile infants in the post-pneumococcal conjugate vaccine era. , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[8]  J. Avner,et al.  Occult bacteremia in the post-pneumococcal conjugate vaccine era: does the blood culture stop here? , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[9]  M. Wilkinson,et al.  Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[10]  L. Baraff Management of infants and young children with fever without source. , 2008, Pediatric annals.

[11]  M. de Martino,et al.  Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children , 2008, Journal of medical microbiology.

[12]  R. Jhaveri,et al.  Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine , 2008, Archives of Disease in Childhood.

[13]  J. Benito-Fernández,et al.  Pneumococcal Bacteremia Among Infants With Fever Without Known Source Before and After Introduction of Pneumococcal Conjugate Vaccine in the Basque Country of Spain , 2007, The Pediatric infectious disease journal.

[14]  M. Plebani,et al.  Procalcitonin and C-Reactive Protein as Diagnostic Markers of Severe Bacterial Infections in Febrile Infants and Children in the Emergency Department , 2007, The Pediatric infectious disease journal.

[15]  R. Riffenburgh,et al.  Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. , 2007, Annals of emergency medicine.

[16]  A. Marchese,et al.  Active surveillance of Streptococcus pneumoniae bacteremia in Italian children. , 2006, Vaccine.

[17]  S. Mintegi,et al.  Impact of the Pneumococcal Conjugate Vaccine in the Management of Highly Febrile Children Aged 6 to 24 Months in an Emergency Department , 2006, Pediatric emergency care.

[18]  R. Vinci,et al.  An Analysis of Pediatric Blood Cultures in the Postpneumococcal Conjugate Vaccine Era in a Community Hospital Emergency Department , 2006, Pediatric emergency care.

[19]  S. Black,et al.  Changing Epidemiology of Outpatient Bacteremia in 3- to 36-Month-Old Children After the Introduction of the Heptavalent-Conjugated Pneumococcal Vaccine , 2006, The Pediatric infectious disease journal.

[20]  L. Rubin,et al.  Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. , 2004, Archives of pediatrics & adolescent medicine.

[21]  L. Baraff Editorial: Clinical policy for children younger than three years presenting to the emergency department with fever. , 2003, Annals of emergency medicine.

[22]  Acepclinicalpoliciescommittee Clinical policy for children younger than three years presenting to the emergency department with fever. , 2003, Annals of emergency medicine.

[23]  M. Harper,et al.  Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. , 2001, Pediatrics.

[24]  L. Baraff Management of fever without source in infants and children. , 2000, Annals of emergency medicine.

[25]  E. Alpern,et al.  Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. , 2000, Pediatrics.

[26]  M. Harper,et al.  Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. , 1998, Archives of pediatrics & adolescent medicine.

[27]  J. Steiner,et al.  Chart reviews in emergency medicine research: Where are the methods? , 1996, Annals of emergency medicine.

[28]  L. Baraff Management of infants and children 3 to 36 months of age with fever without source. , 1993, Pediatric annals.

[29]  D. Schriger,et al.  Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. , 1993, Annals of emergency medicine.